COVID-19
Guidance for the Health Sector
Last reviewed | June 26, 2023 |
---|---|
Last updated | June 26, 2023 |
- Case Definition
- How to help
- Guidance Documents
- COVID-19 Vaccine-Relevant Information and Planning Resources
- For Controlled Drugs and Substances (CDS) prescribers
- Signage
- Related Information
Case Definition
The case definition for COVID-19 has been updated and is current as of June 9, 2023. This information may change frequently, please check back often for updates.
For clinical testing purposes: health professionals who are involved in the assessment and management of possible COVID-19 cases are encouraged to consult Tables 1 and 2 in the daily WHO Situation Report to help inform their decision making.
How to help
We are looking for people with experience in health care who can help us to prevent and control the spread of COVID-19.
Visit our Health Workforce Matching Portal if you're a:
- health care provider working part-time and want to increase your work hours, a former health care provider who is retired or on inactive status, or a health care provider in training and you'd like to be matched to positions and opportunities where services are needed most
- health care facility and would like to request help from available resources
Guidance Documents
Guidance documents on COVID-19 have been produced for a number of health and other sectors.
Note: To the extent that any guidance document conflicts with a Directive issued by the Chief Medical Officer of Health under s. 77.7 of the Health Protection and Promotion Act, the Directive prevails.
Health Sector Resources
Document title | Date |
---|---|
COVID-19 Guidance: Personal Protective Equipment (PPE) for Health Care Workers and Health Care Entities |
June 10, 2022 |
Infection Prevention and Control Hubs | November 10, 2020 |
COVID-19 Guidance: Acute Care Note: The content from this document is now contained within the Appendix: Diseases caused by a novel coronavirus, including Coronavirus Disease (COVID-19), Severe Acute Respiratory Syndrome (SARS) and Middle East Respiratory Syndrome (MERS). |
June 9, 2023 |
Guidance for Mental Health and Addictions Service Providers in Community Settings | September 24, 2020 |
Long-Term Care Home / Retirement Homes Resources
Document title | Date |
---|---|
COVID-19 Guidance: Long-Term Care Homes, Retirement Homes and Other Congregate Living Settings for Public Health Units | June 26, 2023 |
Ministry for Seniors and Accessibility COVID-19 Guidance Document for Retirement Homes in Ontario | June 26, 2023 |
Screening Tool for Long-Term Care Homes and Retirement Homes | August 31, 2022 |
COVID-19 guidance document for long-term care homes in Ontario | June 26, 2023 |
Minister’s Directive: COVID-19 response measures for long-term care homes | June 10, 2022 |
COVID-19 Test Requisition | June 12, 2020 |
Symptoms, Screening, and Testing Resources
Document title | Date |
---|---|
COVID-19 Provincial Testing Guidance | January 25, 2023 |
COVID-19 Screening Tool videos for the hearing impaired | December 3, 2021 |
Guidance for Employers Managing Workers with Symptoms within 48 Hours of COVID-19 Immunization | November 30, 2021 |
COVID-19 Guidance: Testing of Individuals in Pharmacies | November 18, 2021 | Coronavirus Disease 2019 (COVID-19) Testing - PHO | April 18, 2020 |
Considerations for Privately-Initiated Testing | May 21, 2021 |
COVID-19 Patient Screening Guidance Document | August 26, 2021 |
Case and Contact Management Resources
Document title | Date |
---|---|
Management of Cases and Contacts of COVID-19 in Ontario
Note: The content from this document is now contained within the Appendix: Diseases caused by a novel coronavirus, including Coronavirus Disease (COVID-19), Severe Acute Respiratory Syndrome (SARS) and Middle East Respiratory Syndrome (MERS). |
June 9, 2023 |
Guidance for Other Sectors
Document title | Date |
---|---|
Outbreak Guidance: Workplace and Living Settings for Seasonal International Agriculture Workers (IAWs) | June 9, 2023 |
For Controlled Drugs and Substances (CDS) prescribers
Health Canada is moving forward with regulatory exemptions to improve pharmacological and therapeutic options for allowing patients to access controlled medications during the COVID-19.
Health Canada Exemption and Interpretive Guide for Controlled Substances.
Signage
The following signage has been created for businesses and health care settings.
Document title | Date |
---|---|
Patients - English | August 26, 2021 |
Patients - French | August 26, 2021 |
Visitors - English | August 26, 2021 |
Visitors - French | August 26, 2021 |
Related Information
Ontario.ca/COVID-19
Contacting your Public Health Unit
What we know so far - PHO
Government of Canada COVID-19 Outbreak update
Health811: 811